Specific DNA methylation sites on the dopamine transporter gene differed between cannabis-dependent people and controls
While overall methylation of the dopamine transporter gene promoter did not differ between 201 cannabis-dependent patients and 285 controls, specific methylation sites bound by key transcription factors showed significant differences.
Quick Facts
What This Study Found
No overall difference in DAT1 gene promoter methylation was found between groups. However, individual CpG sites showed significant methylation differences, particularly at sites bound by transcription factors involved in nervous system development (SP1, p53, PAX5, GR).
Key Numbers
201 cannabis-dependent patients, 285 matched controls. Significant differences at individual CpG sites bound by SP1, p53, PAX5, and GR transcription factors.
How They Did This
Case-control study comparing DNA methylation patterns in the DAT1 gene promoter between 201 cannabis-dependent patients and 285 age- and sex-matched healthy controls. DNA was extracted from peripheral blood, bisulfite-converted, and sequenced.
Why This Research Matters
The dopamine transporter is central to reward and addiction. Finding that specific methylation sites differ in cannabis-dependent individuals could help explain why some people are more vulnerable to cannabis dependence.
The Bigger Picture
Epigenetic modifications like DNA methylation represent a mechanism by which environmental exposures (including drug use) can alter gene expression without changing the DNA sequence, potentially contributing to or resulting from addiction.
What This Study Doesn't Tell Us
Cross-sectional design cannot determine whether methylation differences preceded or resulted from cannabis dependence. Blood cell methylation may not perfectly reflect brain methylation. The clinical significance of the specific CpG site differences is unknown.
Questions This Raises
- ?Do these methylation changes occur before or after cannabis dependence develops?
- ?Could methylation patterns serve as biomarkers for dependence vulnerability?
- ?Do the affected transcription factor binding sites actually alter dopamine transporter expression?
Trust & Context
- Key Stat:
- Specific CpG sites at SP1, p53, PAX5, GR binding sites differed
- Evidence Grade:
- Moderate: adequate sample size with matched controls, though cross-sectional design and peripheral blood measurements.
- Study Age:
- Published in 2020 in Brain Sciences.
- Original Title:
- Contribution of Dopamine Transporter Gene Methylation Status to Cannabis Dependency.
- Published In:
- Brain sciences, 10(6) (2020)
- Authors:
- Grzywacz, Anna(3), Barczak, Wojciech, Chmielowiec, Jolanta(3), Chmielowiec, Krzysztof, Suchanecka, Aleksandra, Trybek, Grzegorz, Masiak, Jolanta, Jagielski, Paweł, Grocholewicz, Katarzyna, Rubiś, Blazej
- Database ID:
- RTHC-02591
Evidence Hierarchy
Compares people with a condition to similar people without it.
What do these levels mean? →Frequently Asked Questions
What is DNA methylation?
DNA methylation is a chemical modification that can turn genes on or off without changing the genetic code. It is one way that environmental factors, including drug use, can influence how genes function.
Does this mean cannabis dependence is genetic?
Not exactly. The study found epigenetic (not genetic) differences, meaning the DNA sequence was the same but how it was read differed. These changes could be a cause or consequence of cannabis dependence, and environmental factors play a role alongside genetics.
Read More on RethinkTHC
- cannabis-cardiovascular-heart-risk-stroke
- cannabis-heart-cardiovascular-risk
- coughing-up-stuff-after-quitting-weed
- lung-recovery-after-quitting-smoking-weed
- lung-recovery-quitting-weed
- quitting-weed-female-hormones
- quitting-weed-weight-gain-loss-diet-appetite
- sex-after-quitting-weed
- weed-DUI-driving-impaired-cannabis-laws
- weed-acne-skin
- weed-fertility-sperm
- weed-gut-digestion-problems
- weed-heart-health
- weed-testosterone-levels
Cite This Study
https://rethinkthc.com/research/RTHC-02591APA
Grzywacz, Anna; Barczak, Wojciech; Chmielowiec, Jolanta; Chmielowiec, Krzysztof; Suchanecka, Aleksandra; Trybek, Grzegorz; Masiak, Jolanta; Jagielski, Paweł; Grocholewicz, Katarzyna; Rubiś, Blazej. (2020). Contribution of Dopamine Transporter Gene Methylation Status to Cannabis Dependency.. Brain sciences, 10(6). https://doi.org/10.3390/brainsci10060400
MLA
Grzywacz, Anna, et al. "Contribution of Dopamine Transporter Gene Methylation Status to Cannabis Dependency.." Brain sciences, 2020. https://doi.org/10.3390/brainsci10060400
RethinkTHC
RethinkTHC Research Database. "Contribution of Dopamine Transporter Gene Methylation Status..." RTHC-02591. Retrieved from https://rethinkthc.com/research/grzywacz-2020-contribution-of-dopamine-transporter
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.